Lecithin

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Summary

Lecithin is fatty substances commonly found in nutritional supplements.

Generic Name
Lecithin
DrugBank Accession Number
DB15834
Background

A complex mixture of phospholipids, glycolipids, triglycerides, phosphatidylcholines, phosphatidylethanolamines, and phosphatidylinositols.

Type
Small Molecule
Groups
Experimental
Synonyms
  • Lecithins
  • Phosphatidylcholine
  • Phospholutein
External IDs
  • LT-02

Pharmacology

Indication

Not Available

Pharmacology
Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Contraindications
Avoid life-threatening adverse drug events
Improve clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Adverseeffects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Products2
Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
MENAPHASE FORMULA FILM TABLET, 90 ADETLecithin (18 mg) + Ascorbic acid (42 mg) + Biotin (0.05 mg) + Calcium (167 mg) + Choline (3.1 mg) + Chromium (0.0217 mg) + Copper (0.33 mg) + Cyanocobalamin (0.0083 mg) + Ferrous gluconate (3 mg) + Folic acid (0.067 mg) + Inositol (3.1 mg) + Iodine (0.0025 mg) + Magnesium oxide (84 mg) + Manganese (0.6 mg) + Molybdenum (0.0083 mg) + Niacin (8.3 mg) + Calcium pantothenate (8.3 mg) + Phosphorus (35 mg) + Potassium citrate (8.3 mg) + Pyridoxine (16.7 mg) + Riboflavin (8.5 mg) + Selenium (0.0117 mg) + Thiamine (7.5 mg) + Vitamin A (833 IU) + Vitamin D (67 IU) + Vitamin E (67 IU) + Zinc (2.5 mg)TabletOralFERROSAN SAĞLIK ÜRÜN VE HİZMETLERİ A.Ş.2020-08-14Not applicableTurkey flag

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
Not Available
CAS number
8002-43-5

References

General References
Not Available
RxNav
8214
Wikipedia
Lecithin

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4CompletedTreatmentAcute Liver Injury, Drug Induced1
4Unknown StatusTreatmentHepatitis B Chronic Infection1
3CompletedTreatmentHepatic and Hepatobiliary Disorders1
3CompletedTreatmentUlcerative Colitis1
3Not Yet RecruitingTreatmentFear of open spaces / Generalized Anxiety Disorder / Panic Disorder / Social Anxiety Disorder (SAD)1
3TerminatedTreatmentUlcerative Colitis2
3WithdrawnTreatmentAutoimmune Hepatitis (AIH)1
2CompletedTreatmentAcute Liver Injury, Drug Induced1
2CompletedTreatmentPhosphatidylcholine / Ulcerative Colitis1
2CompletedTreatmentUlcerative Colitis1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Capsule, gelatin coatedOral
GelTopical
Capsule, gelatin coatedOral
CapsuleOral
Capsule, liquid filledOral
TabletOral
CapsuleOral
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
Not Available
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Drug created on September 14, 2020 21:52 / Updated on July 03, 2021 01:49